---
pmid: '19759537'
title: Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
authors:
- Huang SM
- Mishina YM
- Liu S
- Cheung A
- Stegmeier F
- Michaud GA
- Charlat O
- Wiellette E
- Zhang Y
- Wiessner S
- Hild M
- Shi X
- Wilson CJ
- Mickanin C
- Myer V
- Fazal A
- Tomlinson R
- Serluca F
- Shao W
- Cheng H
- Shultz M
- Rau C
- Schirle M
- Schlegl J
- Ghidelli S
- Fawell S
- Lu C
- Curtis D
- Kirschner MW
- Lengauer C
- Finan PM
- Tallarico JA
- Bouwmeester T
- Porter JA
- Bauer A
- Cong F
journal: Nature
year: '2009'
full_text_available: false
doi: 10.1038/nature08356
---

# Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
**Authors:** Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, Hild M, Shi X, Wilson CJ, Mickanin C, Myer V, Fazal A, Tomlinson R, Serluca F, Shao W, Cheng H, Shultz M, Rau C, Schirle M, Schlegl J, Ghidelli S, Fawell S, Lu C, Curtis D, Kirschner MW, Lengauer C, Finan PM, Tallarico JA, Bouwmeester T, Porter JA, Bauer A, Cong F
**Journal:** Nature (2009)
**DOI:** [10.1038/nature08356](https://doi.org/10.1038/nature08356)

## Abstract

1. Nature. 2009 Oct 1;461(7264):614-20. doi: 10.1038/nature08356. Epub 2009 Sep
16.

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.

Huang SM(1), Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, 
Wiellette E, Zhang Y, Wiessner S, Hild M, Shi X, Wilson CJ, Mickanin C, Myer V, 
Fazal A, Tomlinson R, Serluca F, Shao W, Cheng H, Shultz M, Rau C, Schirle M, 
Schlegl J, Ghidelli S, Fawell S, Lu C, Curtis D, Kirschner MW, Lengauer C, Finan 
PM, Tallarico JA, Bouwmeester T, Porter JA, Bauer A, Cong F.

Author information:
(1)Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, 
Cambridge, Massachusetts 02139, USA.

Comment in
    Nature. 2009 Oct 1;461(7264):599-600. doi: 10.1038/461599a.

The stability of the Wnt pathway transcription factor beta-catenin is tightly 
regulated by the multi-subunit destruction complex. Deregulated Wnt pathway 
activity has been implicated in many cancers, making this pathway an attractive 
target for anticancer therapies. However, the development of targeted Wnt 
pathway inhibitors has been hampered by the limited number of pathway components 
that are amenable to small molecule inhibition. Here, we used a chemical genetic 
screen to identify a small molecule, XAV939, which selectively inhibits 
beta-catenin-mediated transcription. XAV939 stimulates beta-catenin degradation 
by stabilizing axin, the concentration-limiting component of the destruction 
complex. Using a quantitative chemical proteomic approach, we discovered that 
XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 
1 and tankyrase 2. Both tankyrase isoforms interact with a highly conserved 
domain of axin and stimulate its degradation through the ubiquitin-proteasome 
pathway. Thus, our study provides new mechanistic insights into the regulation 
of axin protein homeostasis and presents new avenues for targeted Wnt pathway 
therapies.

DOI: 10.1038/nature08356
PMID: 19759537 [Indexed for MEDLINE]
